The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 29 October 2001. doi:10.1084/jem.194.9.1231
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 259K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castrillo, A.
Right arrow Articles by Boscá, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castrillo, A.
Right arrow Articles by Boscá, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2001/11/1231/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 9, November 5, 2001 1231-1242

Original Article

Protein Kinase C{epsilon} Is Required for Macrophage Activation and Defense Against Bacterial Infection

Antonio Castrillo1, Daniel J. Pennington2, Florian Otto3, Peter J. Parker2, Michael J. Owen2 and Lisardo Boscá1

1 Instituto de Bioquímica (Centro Mixto Consejo Superior de Investigaciones Cientificas-UCM), Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain
2 Imperial Cancer Research Fund, London WC2A 3PX, United Kingdom
3 Universitaetsklinik, Nothnagel-Laboratorien, D-79106 Freiburg, Germany

Address correspondence to Lisardo Boscá, Instituto de Bioquímica, Facultad de Farmacia, 28040 Madrid, Spain. Phone: 34-91394-1853; Fax: 34-91544-7254; E-mail: boscal{at}eucmax.sim.ucm.es

To assess directly the role of protein kinase C (PKC){epsilon} in the immune system, we generated mice that carried a homozygous disruption of the PKC{epsilon} locus. PKC{epsilon}-/- animals appeared normal and were generally healthy, although female mice frequently developed a bacterial infection of the uterus. Macrophages from PKC{epsilon}-/- animals demonstrated a severely attenuated response to lipopolysaccharide (LPS) and interferon (IFN){gamma}, characterized by a dramatic reduction in the generation of NO, tumor necrosis factor (TNF)-{alpha}, and interleukin (IL)-1ß. Further analysis revealed that LPS-stimulated macrophages from PKC{epsilon}-/- mice were deficient in the induction of nitric oxide synthase (NOS)-2, demonstrating a decrease in the activation of I{kappa}B kinase, a reduction in I{kappa}B degradation, and a decrease in nuclear factor (NF){kappa}B nuclear translocation. After intravenous administration of Gram-negative or Gram-positive bacteria, PKC{epsilon}-/- mice demonstrated a significantly decreased period of survival. This study provides direct evidence that PKC{epsilon} is critically involved at an early stage of LPS-mediated signaling in activated macrophages. Furthermore, we demonstrate that in the absence of PKC{epsilon}, host defense against bacterial infection is severely compromised, resulting in an increased incidence of mortality.

Key Words: nitric oxide • protein kinase C • nitric oxide synthase • macrophage activation • bacterial infection


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS